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Summary 
By generating phosphorylcholine (PC)-specific,  wild-type (#), and chimeric (/z-I-Ao  0  antigen 
receptor transfectants of mature B cells, we have shown that the COOH terminus of the/z heavy 
chain is essential for three major functions: immediate signal transduction (measured as changes 
in intracdlular Ca2+),  antigen presentation, and induction of immunoglobulin M  secretion. 
A more detailed analysis of structural requirements of the COOH-terminal domains contributing 
to  these  functions  was  achieved  by  systematically  replacing  the  spacer,  cytoplasmic,  and 
transmembranal domains of the/z-I-Aol chimeric chain with those of/~. Using this rescue approach, 
we show that the carboxyl two-thirds of the transmembranal domain (proximal to the cytoplasmic 
domain) is required for induction of intracellular Ca  2  +, whereas the complete transmembranal 
domain is required for the function of antigen presentation but is dispensable for induction of 
antibody secretion. 
M 
embrane IgM  (mlgM)  1 molecules serve as antigen- 
specific receptors on mature B cells (1). The crosslinking 
of these receptors with antigen induces a complex series of 
biochemical reactions (2, 3). Some of the documented im- 
mediate biochemical changes include hydrolysis of phosphatidyl 
inositol into inositol 1,4,5  triphosphate and diacylglycerol 
(DAG),  followed by a rise in intracellular Ca  2+ levels (4). 
DAG and Ca  2  + lead to activation of protein kinase C (PKC), 
which might be involved in induction of various immediate 
early genes (5-7). In addition, recent studies indicate activa- 
tion of tyrosine kinase(s) immediately after crosslinking of 
mIgM (8-10).  While these and various other biochemical 
changes are taking place, the mIgM receptor is endocytosed, 
ligand is processed,  and  some of the ligand peptides are 
presented to T cells in a MHC class II-restricted fashion (11). 
The resulting cognate B-T cell interaction leads to lymphokine 
secretion (12), which in turn helps mature B cells to differen- 
tiate into plasma cells (13). 
The extracellular NH2 terminus of mIgM endows it with 
antigen specificity, whereas the membrane-associated COOH 
terminus, in concert with associated proteins, appears to be 
1 Abbreviations used in this  pala,  r: DSM, domain shuffle mutagenesis; HEL, 
hen egg lysozyme; Id, idiotype; mIgM, membrane immunoglobulin M; 
PKC, protein kinase C; TM, transmembranal. 
involved in initiating the cascade of reactions mentioned above 
(14). We have shown that the COOH terminus is required 
for antigen-specific induction of intraceilular Ca  2  + levels, in- 
duction of immediate early gene messages, and growth ar- 
rest in CH33 cells (15), but not for endocytosis of ligand- 
receptor complexes (16). This was achieved by replacing 40 
amino acids of the COOH terminus of mlgM with the equiva- 
lent segment from the COOH terminus of MHC class II 
I-Abol (17). The COOH terminus can be divided into three 
hypothetical domains: spacer, transmembranal (TM), and cy- 
toplasmic (Fig.  1).  Here,  by domain shuffle  mutagenesis 
(DSM), we have tried to define the structural requirements 
of the TM domain (summarized in Fig. 1 c) for different func- 
tions, such as induction of intracdlular Ca  2+ levels, antigen 
presentation, and induction of secretion. 
Materials and Methods 
Reagents.  ALl reagents except hypoxanthine, xanthine, thymi- 
dine, adenine, and acetomethyl-ester  of indo 1 (Indo 1-AM) were 
purchased from Gibco Laboratories (Grand Island, NY). The Indo 
1-AM was purchased from Molecular Probes (Eugene, OK),  and 
the remaining reagents were purchased from Sigma Chemical Co. 
(St. Louis, MO). Purified anti-T15-idiotype  (Id)  + antibody, AB1-2 
(18), and fluorescein-conjugated  goat anti-mouse IgG1 were ob- 
tained from Southern Biotechnology  Associates  (Birmingham,  AL). 
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munoresearch Laboratories (West Grove, PA). 
Plasmid Construction.  All plasmid constructs contain Escherichia 
coli ampicillin and guanin  e phosphoribosyl transferase genes and 
routine genomic sequences for productively  rearranged  VHS107-C# 
and V~ 22-C, Ig chains (19). The chimeric phsmid with the I-Abce 
tail (Fig. 1 b) was made by replacing a 1.7-kb fragment spanning 
ml and m2 exons of the/Z heavy chain with a 2.8-kb fragment 
spanning the membrane exon and 3' untranslated region of the 
MHC  class II  I-Abce chain  (17). Similarly, all  other  mutant 
plasmids were made by replacing the 1.7-kb # membrane exons 
containing fragment with mutant fragments (see below). 
Domain Shuffle Mutagenesis.  The 700-bp fragment containing 
only the membrane exon of the class II I-Ace  chain was cloned into 
M13 bacteriophage. Single-stranded  DNA was generated and used 
to construct domain shuffle mutant/Z-S-C  (Fig. 1), by standard 
site-directed mutagenesis (20). This 700-bp mutant fragment was 
then cloned in front of the 2.1-kb 3' untranslated region of the 
MHC class II I-Ace chain. This 2.8-kb fragment carrying muta- 
tion was then used to replace 1.7-kb/z membrane exons  containing 
fragment. Mutants TM1 and TM2 (Fig. 1) were made by the PCR 
sowing technique (21). Initially, the mutant/z-S (/z-spacer, I-Ace 
TM, and cytoplasmic)  mutant was made by standard site-directed 
mutagenesis. This mutant fragment and the 1.7-kb/z membrane 
exons fragment were used as templates for the PCR sowing tech- 
nique. All the mutants were sequenced by the dideoxy sequencing 
method to confirm the changes made. 
Parental Cells and TI5-Id  +-transferred Celt Lines.  BCL1  (/z +,/~  +, 
I-A  d) (22) and CH12.LX (/z+, ~+, I-A  k, Ly-1  +) (23) murine B cell 
lymphomas were used as parental cell lines in all experiments. T15- 
Id + transfectants were generated by electroporating 10-15/zg of 
linearized plasmid DNA into the parental cells (24). Transfected 
cells were selected  by their resistance to mycophenolic  acid and then 
were cloned by limiting dilution. 
Immunofluorescent Staining.  Surface  expression of the T15-Id on 
transfected cells was determined by staining with AB1-2 followed 
by fluorescein-conjugated  goat anti-mouse IgG1 antibody (18). As 
controls, nontransfected parental ceUs were stained for T15-Id and 
transfectants  were stained with  fluorescein-conjugated goat 
anti-mouse  IgG1 alone. Staining  profiles were analyzed by 
FACScan  |  (Becton Dickinson & Co., Mountain View, CA). 
Calcium Analysis.  Changes in Ca  2+ levels were measured by 
cell sorter (Ortho Diagnostics Systems, Westwood, MA) as de- 
scribed (25). Briefly, cdls grown to log-phase were loaded with 
the Indo-l-AM (10/zM/6-7  x  l& cells) for 25 min and were then 
allowed to equilibrate in 10-fold excess medium for 25 min in the 
dark at 37~  The cell sorter analysis  was done at the rate of'~350 
cellsA. The base line was established for 1 min before activating 
cells with the antigen PC-KLH (5/zg/2  x  106 cells/2 ml). Within 
10.20 s after addition of antigen, recording of changes in levels 
of Ca  2+ was resumed. Anti-IgM F(ab')z fragments were used as 
a positive control antibody to check the ability of the ceils to in- 
duce a rise in intracellular Ca  2+. Data were analyzed using the 
"Cicero Ca  2+  analysis" program. 
Antigen Presentation.  Antigen presentation was carried out as 
previously described (26). Briefly, 5  x  103 cells of the T cell hy- 
bridoma, CPC-1-8, derived from BALB/c mice (27), were cocul- 
tured with l& cells of BCL1 parental or transfected  cells in a total 
volume  of  200/zl in the presence  of  various concentrations  of  PC-hen 
egg lysozyme (PC-HEL) or PBS at 37~  for 20.24 h. The ability 
of the culture  supernatants to support  the growth of an IL-2- 
dependent cell line, CTLL-2, was then determined. 100/zl of cul- 
ture supernatant was incubated with 5 x  103 CTLL2 cells in total 
volume of 200 #1 RPMI 1640 supplemented with 5% FCS. After 
20-24 h, cells were pulsed with [SH]dTR (1/zCi/well) for 12-16 h 
and harvested on glass filters (Whatman Inc., Clifton, NJ). The 
[3H]dTR uptake was measured  in a scintilhtion counter (Beckman 
Instruments,  Inc., Palo Alto, CA). 
Plaque-forming Colony Assays.  Log-phase  transfectants, washed 
thrice with RPMI, were seeded  into a 96-well microtiter plate (1.5 
x  103 cells/well) and incubated with anti-I-E  k antibody (14-4-4S; 
50 ng/ml) and medium alone, or with anti-I-E  k antibody and one 
of the following: anti-CH12-Id  + antibody (5E3; 300 rig/m1), anti- 
T15 antibody (AB1-2; 300 ng/ml), or with PC-KLH (1/zg/ml) 
for 72 h at 37~  in an atmosphere of 5% CO2. After 72 h, cells 
were washed with RPMI, and a fraction of  cells was then analyzed 
for their ability to form plaques as previously described (28). 
Results 
Establishment of Antigen-specifi6  Wild-Type and Mutant Cell 
Lines.  Antigen-specific  transfectants were generated by elec- 
troporating wild-type and mutant plasmid DNAs into pa- 
rental cell lines. The #-I-Ace plasmid was made by replacing 
40 amino acids comprising three domains: spacer, TM, and 
cytoplasmic, with the analogous amino acids from the MHC 
dass II I-Ace (Fig. 1 b). The I-Aoe COOH terminus was chosen 
because  the genomic done was available, it used the same 
RNA-splicing site as/~m, and there is no significant homology 
to #m in any of the COOH-terminal domains. The other 
DSMs (Fig. 1 b) were generated either by site-directed muta- 
genesis or by a PCR sowing technique. Wild-type and mu- 
tant  constructs  were  transfected into  BCL1  (#+,~*,I-A  d) 
(22)  and CH12.LX (#+,  ~+,  I-A  k) (23) B lymphoma cell 
lines.  BCLI  was  used  for  studying an  immediate  signal 
transduction event (induction of Ca  2+  levels) and for an- 
tigen presentation. Parental  and transfected BCL1 cells ex- 
press an MHC haplotype for which T cell dones specific for 
PC-HEL are  available (27),  and they have been shown to 
present antigen (26).  CH12.LX cells were used to study an 
induction of IgM secretion, a measure of B cell differentia- 
tion. These ceUs can be activated by antigen (or antiidiotypic 
antibody) plus anti-MHC class II I-E  ~ antibody, which acts 
as a surrogate for T cell help (23). This phenomenon of in- 
duction of secretion of antibody is not restricted to CH12.LX 
cells since normal B cells can also be triggered to secrete using 
the similar induction protocol.  (29,  30). 
The surface expression  of transfected receptors  was deter- 
mined by immunofluorescence staining with an antiidiotypic 
antibody,  AB1-2  (18) (Fig.  2).  Besides  TM1  and  TM2 
receptors,  all other mutant receptors on BCL1 cells were ex- 
pressed at levels generaUy equivalent to wild-type (Fig. 2 a-c, 
g, and h). Mutant receptors on CH12.LX cells were expressed 
at lower levels (Fig.  2, d-f)  than those on BCL1 cells but 
were higher than wild-type, dismissing the possibility that 
differential functional activities could be ascribed to differen- 
tial cell surface expression. 
Induction of Rise in Ca  2+  Can Be Rescued by the Carboxy 
Two-Thirds of the  TM Domain.  An immediate rise  in in- 
tracellular  Ca  2+  was  observed  when  the  wild-type  IgM 
receptors  on the surface of BCL1 transfectants were cross- 
linked with the antigen PC-KLH (Fig. 3 b). The #-I-Aoe tail 
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Figtar 1.  Summary of structures, 
mutations, and results orB cell an- 
tigen receptor domain shuffling. (a) 
Schematic presentation  of mlgM 
molecule denoting the antigen com- 
bining sites and  the  membrane- 
anchored COOH terminus of the 
# heavy chain, which is divided into 
three hypothetical domains: spacer, 
TM, and cytoplasmic. (b) Compar- 
ison of amino acid sequences of the 
COOH terminus of/~ and I-Ace  k 
chains and DSMs. The TM domain 
is divided into three  subdomains: 
TM1, TM2, and TM3. (c) Tabular 
presentation  of/~ and DSMs and 
their abilities (+) or inabilities (-) 
to perform immediate (rise in intra- 
cellu]ar Ca2*), late (antigen presen- 
tation),  and differentiative (secre- 
tion) functions when induced by 
antigen. 
receptor lacked this capacity completely (Fig. 3 c), thus es- 
tablishing the requirement of the COOH terminus. We could 
not rescue this function either by reinserting both #  cyto- 
plasmic and spacer domains (Fig.  3 d) or by reinserting 
cytoplasmic and spacer domains as well as the TM subdo- 
main, TM1 (Fig. 3 e). However, the replacement of both cy- 
toplasmic and spacer domains and two TM subdomains, TM1 
and TM2 (Fig.  3 f), restores  the Ca  2+ response. 
The Antigen Presentation Function Requires the Entire 1r  TM 
Domain.  When the same BCLt transfectants were analyzed 
for their ability to present antigen (PC-HEL) to appropri- 
ately MHC class II-restricted T  cells (31), only wild-type 
(Fig. 4 b), but none of the mutants (Fig. 4, c-f), were able 
to activate T cells to produce II:2. The wild-type receptor 
could present specific antigen (PC-HEL) 10-15 times more 
efficiently than nonspecific antigen (HEL). Our assay condi- 
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Figure 2.  Wild-type and mutant receptors 
expression  on the surface  of~ cell lines. 
In the schematic inserts, filled regions denote 
I-Ao# sequences. R~resentative data of BCL1 
(a-c, g, and h), and CH12.LX (d-f)  transfec- 
tams. The data shown for a single clone of each 
receptor are representative of multiple clones 
analyzed. 
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Figure 3.  The TM1 and TM2 subdomains are essential for induction 
of Ca  2  *. Insets designate the transfected receptor under analysis: (a) no 
receptor; (b)/z; (c)/i-I-Act; (d) #-S-C; (e)/~-TM1;  and (f) #-TM2. At least 
two clones for each receptor were analyzed and the data shown are repre- 
sentative. Changes in intracellular Ca  2+ levels were measured by FACS  | 
(Ortho 50HH cell sorter and Cicero computer; Cicero Cytomation, Fort 
Collins, CO) as described (29). The data were analyzed using the Cicero 
Ca  2+  analysis program. 
tions yielded specific antigen presentation  within the con- 
centration range of 0.1-5/zg of antigen concentration. At 
higher concentrations,  such as 15/zg,  all cells could present 
specific and nonspecific antigens with equal efficiency (data 
not shown). Thus, the segment of the/~ TM domain prox- 
imal to the exterior is dispensible for the immediate Ca  2+ 
activation event, but the complete TM domain is necessary 
for the subsequent  function of antigen processing. 
Induction of Antibody Secretion Does Not Require the ~  TM 
Domain.  A 5-10-fold induction in secretion was observed 
when wild-type transfectants of CH12.LX were induced with 
either PC-KLH or anti-T15-Id antibody (AB1-2) and anti- 
I-E  k antibody (Fig. 4). As with other functions, the replace- 
ment of all three domains with that of MHC class II I-Aoe 
completely abolished this induction (Fig. 4). However, secre- 
tion could be rescued by reinserting the #  spacer and cyto- 
plasmic domains, suggesting that residues and/or conforma- 
tion unique to  the /i  TM  segment are not  required  for 
induction of secretion in these cells. 
Discussion 
Using the DSM approach, we have segregated differential 
structural requirements of the TM domain for three major 
functions of the mlgM antigen receptor. Residues located 
in all three operationally defined TM subdomains are neces- 
sary for antigen presentation, whereas residues in the exterior 
proximal (TM3) segment can be replaced without affecting 
Ca  2  + flux.  The complete replacement  of the TM domain 
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Figure 4.  Entire TM domain comprising TMI, TM2, and TM3 sub- 
domains is required for the function of antigen presentation. The ability 
of the supernatants, from cocultures of BCL1 parental cell (a) or BCL1 
transfectant (b-f) and T cell hybridoma CPC-18 in presence of various 
concentrations  of specific antigen (PC-HEL;  O) or nonspecific antigen 
(HEL; O), to support the growth of an IL-2-dependent cell line CTLL-2, 
was considered as a measure of antigen presentation. The insets represent 
the transfected receptor under analysis: (a) no receptor; (b)/z; (c) #-I-Ace; 
(d)/z-S-C; (e) #-TM1; 0  c) #-TM2. 
can support third-function, receptor-mediated antibody secre- 
tion. A potential  complication  in our approach is that the 
parental cell lines used express their own heavy and light chains. 
Conceivably these could associate with transfected chains to 
produce various heterodimeric combinations. Since  PC binding 
requires  appropriate  heavy and light chains, heterodimers 
would either be nonfunctional or monovalent. Given the high 
affinity of T15 chains to reassociate with themselves (32), 
we do not anticipate a high fraction  of heterodimers,  and 
for that matter, their fractions should be effectively the same 
in wild-type or mutant cells. Furthermore, if heterodimers 
of the monovalent type existed at measurable levels one might 
anticipate an artifactuaUy high response in all cells, assuming 
that a single wild-type TM region is sufficient. That we ob- 
serve differential responses among mutants is incompatible 
with this  argument. 
A point mutational analysis (33) has shown that the cyto- 
plasmic tail as well as a dipeptide (YS) within the TM1 sub- 
domain are essential for Ca  2+  induction.  Our results  are 
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Figure 5.  The TM domain is not essential for induction of antibody 
secretion  in CH12.LX B cells. The secretion  oflgM was analyzed  as plaque- 
forming colonies (pfc) and is presented as number of pfc/10  6 recovered 
for wild-type  (#),/~-I-Aot,  or #-S-C transfectant  cells. Log-phase  transfec- 
tants were incubated  with anti-I-E  k antibody  and medium alone (dotted 
bars), or with anti I-E  k antibody, and one of the following: anti-CH12 
Id + antibody (filled bars), anti-T15 antibody (stippled  ban), or with PC- 
KLH (open  bars). Data shown for one clone  of each receptor  are represen- 
tative of two clones analyzed. 
consistent with their findings, but indicate further that these 
TM1 residues alone are insufficient and that TM2 along with 
spacer and cytoplasmic domains are required for Ca  2  + induc- 
tion. There are several polar residues within the/~ TM2 sub- 
domain that have no counterparts in I-Aot. These might be 
associated with B29 (34), rob-1 (35), or other, yet to be de- 
scribed accessory polypeptides. Alternatively, the conforma- 
tion of the TM1 and TM2 subdomains might be the essen- 
tial feature. 
Antigen presentation first demands endocytosis of ligand- 
receptor complexes and  then  routing  of these complexes 
through a defined endocytic pathway. Previously, we have 
shown that endocytosis of ligand-receptor complexes does 
not depend upon the #  COOH terminus (16). However, as 
presented here, the complete TM domain is essential for the 
ultimate outcome of this process,  measured as activation of 
T cells. Even though ligand-receptor complexes are endocy- 
tosed, their delivery to the appropriate endocytic compart- 
ment for processing appears  to depend on TM residues.  A 
requirement of the tyrosine within the/~ TM1 domain and 
the cytoplasmic tail for antigen presentation has been demon- 
strated (33).  Our experiments implicate a requirement for 
the TM2 and TM3 segments as well. With respect to the 
TM3 subdomain, indirect evidence suggests that all or part 
of the polar segment TAST (Fig.  1 b) is associated with an 
accessory molecule (36). Antigen presentation was not affected 
by mutation of the carboxyl two residues (TAST to TAW) 
(33) but was completely eliminated when we rephced all eight 
TM3 residues with those of the I-Ac~ chain. A proposal that 
accommodates the above findings is that the NH2-terminal 
T of TAST is essential for antigen presentation. This polar res- 
idue is an attractive candidate for facilitating interaction be- 
tween IgM and the putative accessory molecule. Another pos- 
sibility for loss of function by the TM2 mutant is the altera- 
tion in the conformation of the TM3  subdomain. 
Given the structural requirements of the #  TM domain 
for Ca  2+ mobilization and antigen presentation, its dispens- 
ability for induction of antibody secretion was unanticipated. 
Events regulating secretion have been documented at tran- 
scriptional termination, RNA processing, and posttransla- 
tional levels (37).  The former two mechanisms are known 
to be susceptible to membrane-generated, signal transduc- 
tion events (38, 39). The #-S-C receptor is incapable of im- 
mediate signal transduction (Figs.  1 c and 3),  and we ob- 
served no consistent shifts in RNA levels for #m, ks, CK, 
or J chain (data not shown) after antigen induction. There- 
fore, it is probable that the replacement of antigen receptor 
spacer and cytoplasmic domains in CH12.LX cells perturbs 
some downstream event, conceivably by disrupting an inter- 
action with a membrane molecule(s) other than that which 
interacts with transmembranal residues.  Regardless of the 
mechanism, it is unlikely that this phenomenon is restricted 
to CH12.LX since normal B cells can be triggered to secrete 
using a similar induction protocol (29, 30). Mond et al. (40) 
have shown that Ca  z+ elevation and PIP2 hydrolysis can be 
blocked by the PKC inhibitor, indolactam, without blocking 
anti-Ig-mediated B cell proliferation. Taken with our results, 
these data emphasize the importance of defining antigen- 
induced TM signaling events other than Ca  2+ flux that are 
critical for stimulating B cell growth and differentiation. 
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